Trade KNSA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kiniksa Pharmaceuticals International, plc Class A (KNSA) is trading at US$77.24, down 2.63% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$6.17B. Over the past 52 weeks, KNSA has traded between US$35.20 and US$82.94. On Syfe you can trade KNSA with $0 commission and add it to your watchlist.
| Previous close | US$79.33 |
|---|---|
| Market cap | US$6.17B |
| P/E ratio | 41.36 |
| 52-week range | US$35.20 – US$82.94 |
| Volume | 1.03M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kiniksa Pharmaceuticals International, plc Class A
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Year: 2018
Top Midday Gainers
Jul 28, 6:26 PM · MT Newswires
Kiniksa's Arcalyst Growth Outlook Strengthens, Wedbush Says
Jul 28, 3:40 PM · MT Newswires
Wedbush Raises Price Target on Kiniksa Pharmaceuticals to $99 From $72, Maintains Outperform Rating
Jul 28, 2:41 PM · MT Newswires
Kiniksa Pharmaceuticals International Q2 Net Income, Revenue Increase
Jul 28, 11:50 AM · MT Newswires
--Earnings Flash (KNSA) Kiniksa Pharmaceuticals Posts Q2 EPS $0.30, vs. FactSet Est of $0.28
Jul 28, 11:35 AM · MT Newswires
Kiniksa Pharmaceuticals International, plc Class A (KNSA) stock is trading at US$77.24, -2.63% from the previous close of US$79.33.
The market cap for Kiniksa Pharmaceuticals International, plc Class A (KNSA) stock is approximately US$6.17B.
The price-to-earnings ratio for Kiniksa Pharmaceuticals International, plc Class A (KNSA) is 41.36, based on the latest reported earnings.
The 52-week high for Kiniksa Pharmaceuticals International, plc Class A (KNSA) stock is US$82.94.
The 52-week low for Kiniksa Pharmaceuticals International, plc Class A (KNSA) stock is US$35.20.
Kiniksa Pharmaceuticals International, plc Class A (KNSA) does not currently pay a dividend.
Stay on top of KNSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
